SEC Form 4 · accession 0001615774-15-001285
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne-Marie Juliette Ripley
Officer — VP Regulatory Affairs
Period of report
May 26, 2015
Accepted (ET)
May 28, 2015 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | May 26, 2015 | M | 8,716 | $4.75 | A | 8,716 | D | |
| COMMON STOCKF2,F3 | May 26, 2015 | S | 8,716 | $13.0283 | D | 0 | D | |
| COMMON STOCKF1 | May 27, 2015 | M | 11,284 | $4.75 | A | 11,284 | D | |
| COMMON STOCKF2,F3 | May 27, 2015 | S | 11,284 | $13.039 | D | 0 | D | |
| COMMON STOCKF1 | May 27, 2015 | M | 25,629 | $4.75 | A | 25,629 | D | |
| COMMON STOCKF2,F3 | May 27, 2015 | S | 25,629 | $13.039 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF1,F3 | $4.75 | May 26, 2015 | M | 8,716 | A | — | Sep 1, 2015 | Common Stock | 8,716 | 124,410 | D |
| OptionF1,F3 | $4.75 | May 27, 2015 | M | 11,284 | A | — | Sep 1, 2015 | Common Stock | 11,284 | 113,126 | D |
| OptionF3 | $4.75 | May 27, 2015 | M | 25,629 | A | — | Sep 1, 2015 | Common Stock | 25,629 | 87,497 | D |
| OptionF3 | $4.75 | holding | — | — | — | — | Sep 1, 2015 | Common Stock | 4,371 | 87,497 | D |
| OptionF3 | $4.75 | holding | — | — | — | — | Jan 1, 2016 | Common Stock | 2,500 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Jan 1, 2017 | Common Stock | 6,125 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Apr 1, 2018 | Common Stock | 4,750 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Nov 1, 2018 | Common Stock | 25,000 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Feb 1, 2019 | Common Stock | 6,750 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 10,125 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 10,625 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Mar 1, 2021 | Common Stock | 8,313 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Mar 1, 2022 | Common Stock | 5,813 | 87,497 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Apr 1, 2024 | Common Stock | 5,813 | 87,497 | D |
Explanation of responses
- F1Ms. Ripley aquired 45,629 shares on exercise of options (which expire on September 1, 2015) reported as Option(1) on Form 3 filed with the SEC on November 18, 2014 and sold those shares as reported in Table I.
- F2These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter.
- F3These are vested employee options currently exercisable.
Remarks
Excludes employee options in amount of 89,781 shares, not vested and not exercisable for over 60 days from this date.